Literature DB >> 19469843

The autosomal recessively inherited progressive myoclonus epilepsies and their genes.

Nivetha Ramachandran1, Jean-Marie Girard, Julie Turnbull, Berge A Minassian.   

Abstract

Autosomal recessively inherited progressive myoclonus epilepsies (PMEs) include Lafora disease, Unverricht-Lundborg disease, the neuronal ceroid lipofuscinoses, type I sialidosis (cherry-red spot myoclonus), action myoclonus-renal failure syndrome, and type III Gaucher disease. Almost all the autosomal recessively inherited PMEs are lysosomal diseases, with the exception of Lafora disease in which neither the accumulating material nor the gene products are in lysosomes. Progress in identifying the causative defects of PME is near-complete. Much work lies ahead to resolve the pathobiology and neurophysiology of this group of devastating disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19469843     DOI: 10.1111/j.1528-1167.2009.02117.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  27 in total

1.  Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.

Authors:  Anna A DePaoli-Roach; Vincent S Tagliabracci; Dyann M Segvich; Catalina M Meyer; Jose M Irimia; Peter J Roach
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 2.  Are there errors in glycogen biosynthesis and is laforin a repair enzyme?

Authors:  Peter J Roach
Journal:  FEBS Lett       Date:  2011-09-16       Impact factor: 4.124

3.  Insights into the mechanism of polysaccharide dephosphorylation by a glucan phosphatase.

Authors:  Vincent S Tagliabracci; Peter J Roach
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-19       Impact factor: 11.205

Review 4.  Lafora disease: epidemiology, pathophysiology and management.

Authors:  Thomas S Monaghan; Norman Delanty
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 5.  Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects.

Authors:  Luis Felipe Mendonça de Siqueira
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

Review 6.  Glycogen phosphorylation and Lafora disease.

Authors:  Peter J Roach
Journal:  Mol Aspects Med       Date:  2015-08-13

Review 7.  Glycogen metabolism and glycogen storage disorders.

Authors:  Shibani Kanungo; Kimberly Wells; Taylor Tribett; Areeg El-Gharbawy
Journal:  Ann Transl Med       Date:  2018-12

8.  A 12-kb structural variation in progressive myoclonic epilepsy was newly identified by long-read whole-genome sequencing.

Authors:  Takeshi Mizuguchi; Takeshi Suzuki; Chihiro Abe; Ayako Umemura; Katsushi Tokunaga; Yosuke Kawai; Minoru Nakamura; Masao Nagasaki; Kengo Kinoshita; Yasunobu Okamura; Satoko Miyatake; Noriko Miyake; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2019-02-13       Impact factor: 3.172

9.  Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.

Authors:  Carolina Courage; Karen L Oliver; Eon Joo Park; Jillian M Cameron; Kariona A Grabińska; Mikko Muona; Laura Canafoglia; Antonio Gambardella; Edith Said; Zaid Afawi; Betul Baykan; Christian Brandt; Carlo di Bonaventura; Hui Bein Chew; Chiara Criscuolo; Leanne M Dibbens; Barbara Castellotti; Patrizia Riguzzi; Angelo Labate; Alessandro Filla; Anna T Giallonardo; Geza Berecki; Christopher B Jackson; Tarja Joensuu; John A Damiano; Sara Kivity; Amos Korczyn; Aarno Palotie; Pasquale Striano; Davide Uccellini; Loretta Giuliano; Eva Andermann; Ingrid E Scheffer; Roberto Michelucci; Melanie Bahlo; Silvana Franceschetti; William C Sessa; Samuel F Berkovic; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2021-04-01       Impact factor: 11.025

10.  Metabolic myopathies.

Authors:  Salvatore DiMauro; Caterina Garone; Ali Naini
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.